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Abstract  51 
Background: Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) is used as 52 
rescue for severe cardiopulmonary failure. We tested whether the ratio of CO2 elimination at the 53 
lung and the V-A ECMO (V̇CO2ECMO/VCO2Lung) would reflect the ratio of respective blood flows 54 
and could be used to estimate changes in pulmonary blood flow (QLUNG), i. e. native cardiac 55 
output.  56 
Methods: Four healthy pigs were centrally cannulated for V-A ECMO. We measured blood flows 57 
with an ultrasonic flow probe. V̇CO2ECMO and V̇CO2Lung were calculated from sidestream 58 
capnographs under constant pulmonary ventilation during V-A ECMO weaning with changing 59 
sweep gas and/or V-A ECMO blood flow. If ventilation/perfusion (V/Q) ratio of V-A ECMO was 60 
not one, the V̇CO2ECMO was normalized to V/Q=1 (V̇CO2ECMONORM). Changes in pulmonary blood 61 
flow were calculated using the relationship between changes in CO2 elimination and V-A ECMO 62 
blood flow. 63 
Results: QECMO correlated strongly with V̇CO2ECMONORM (r2 0.95 – 0.99). QLUNG correlated well 64 
with V̇CO2LUNG (r2 0.65 – 0.89, p<=0.002).  Absolute QLung could not be calculated in a non-65 
steady state. Calculated pulmonary blood flow changes had a bias of 76 (-266 to 418) ml/min 66 
and correlated with measured QLUNG (r2 0.974 – 1.000, p = 0.1 to 0.006) for cumulative ECMO 67 
flow reductions. 68 
Conclusions: V̇CO2 of the lung correlated strongly with pulmonary blood flow. Our model could 69 
predict pulmonary blood flow changes within clinically acceptable margins of error. The 70 
prediction is made possible with a normalization to a V/Q of 1 for ECMO. This approach 71 
depends on measurements readily available and may allow immediate assessment of the 72 
cardiac output response.  73 




Extracorporeal membrane oxygenation (ECMO) is increasingly used as rescue therapy for 75 
severe cardiopulmonary failure (2). In veno-arterial (V-A) ECMO treatment, the native heart and 76 
lung work in parallel with the extracorporeal circuit and the assessment of native cardiac output 77 
(i. e. blood flow through the lungs (QLUNG)) is difficult. The ongoing unloading of the right ventricle 78 
even at low V-A ECMO blood flow (QECMO) makes assessment of cardiac function during V-A 79 
ECMO treatment challenging. Monitoring of the cardiac function and the evolution of native 80 
cardiac output during V-A ECMO treatment are not well standardized. Echocardiography is often 81 
used, but requires specific knowledge (1) and routine echocardiographic parameters may not be 82 
useful in the context because of altered circulatory physiology and changing cardiac loading 83 
conditions (12). Monitoring of the evolution of native cardiac output based on simple, non-84 
invasive and readily available measurements would therefore be helpful in clinical practice, 85 
particularly during weaning, since early weaning success is associated with a favorable 86 
prognosis (9). 87 
Gas exchange during V-A ECMO should reflect the combined effect of ventilation and perfusion 88 
of the native lung and those of the V-A ECMO circuit (21). We hypothesize that during V-A 89 
ECMO weaning the ratio between changes in V̇CO2ECMO and V̇CO2Lung is the same as the ratio 90 
between changes in the respective flows (QECMO and QLUNG). We tested this hypothesis in this 91 
preliminary, hypothesis generating study by measuring the elimination of CO2 over the native 92 
lung and the V-A ECMO and the respective blood flows, and compared the calculated flow 93 
changes with those directly measured from the pulmonary artery and V-A ECMO circuit. 94 




Animal Care, surgery and anesthesia 96 
This study was performed as a preliminary, independent sub-study of a yet unpublished project 97 
evaluating regional abdominal circulation during V-A ECMO and systemic inflammation, where 98 
measurements were done before the main study protocol was started. The study complied with 99 
the Guide for the Care and Use of Laboratory Animals (National Academy of Sciences, 1996) 100 
and Swiss National Guidelines and was approved, including an amendment for this sub-study, 101 
by the Commission of Animal Experimentation of Canton Bern, Switzerland (BE119/17). 102 
We studied a convenience sample of four animals (2 male and female each, 51.5 ± 1.3 kg) 103 
before the main study protocol was started. The pigs fasted for 12h with free access to water. 104 
After anesthesia induction with intravenous midazolam and atropine and oral intubation, 105 
anesthesia was maintained with propofol and fentanyl and the depth was controlled by 106 
repeatedly testing the response to nose pinch in additional to bispectral index target < 60 (BIS™ 107 
Quatro, Covidien, Mansfield, MA). Additional injections of fentanyl (50 µg) or midazolam (5 mg) 108 
were given as needed. Muscle relaxation was induced with rocuronium (0.5 mg/kg). Mechanical 109 
ventilation (volume control mode, PEEP 5 cmH2O, FiO2 0.3) was initiated with a tidal volume of 110 
7 ml/kg and a respiratory rate aiming at an end-tidal pCO2 of 45 mmHg. A 5 French introducer 111 
sheath was placed in the right carotid artery for arterial blood pressure measurement and arterial 112 
blood gas sampling. Two three-lumen central venous lines were placed in the right and left 113 
jugular vein for right atrial pressure measurement and continuous administration of sedatives 114 
and vasopressors. V-A ECMO with right atrial-aortic cannulation and a left atrial vent (Maquet 115 
Cardiohelp, Quadrox MECC oxygenator, Rastatt, Germany and Medtronic cannula and vent, 116 
Minneapolis, MN) were installed via a sternotomy and a bolus of 2.500 IE unfractioned heparin 117 
was given. An appropriately sized ultrasonic flow probe was placed on the pulmonary artery (16 118 
or 18 mm internal diameter, Transonic PAU series, Ithaca, USA).  During surgery, fluid was 119 
supplemented with Ringer's lactate at an initial rate of 5 ml · kg-1 · min-1 and increased to 10ml 120 
· kg-1 · min-1. Any visible blood loss was replaced by hydroxyethyl starch (HES; 6% Voluven; 121 
Fresenius Kabi, Bad Homburg, Germany), and V-A ECMO pump speed adjusted to achieve a 122 
mixed or central venous saturation > 50%.  123 
 124 
Measurements and data recording 125 
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Pulmonary blood flow, i. e. cardiac output (QLUNG) and V-A ECMO blood flow (QECMO) were 126 
measured on the pulmonary artery main trunk and arterial ECMO tubing (Transonic PAU series, 127 
Ithaca, USA). Pulmonary end-tidal pCO2 (etCO2LUNG) and pCO2 at the membrane lung 128 
(peCO2ECMO) were measured with a sidestream capnograph (GE Medical, Module E-COVX with 129 
automated correction to BTPS conditions). The carbon dioxide production (V̇CO2) was 130 
calculated individually for native and membrane lungs from the tidal pCO2 tracing as described 131 
below. We recorded sweep gas flow (VECMO) manually. Arterial blood gases were taken before 132 
and after the study period. Pulmonary ventilation (VLUNG) was kept constant. In the first animal, 133 
ventilator settings were kept identical to those before V-A ECMO (tidal volume (VT) 0.465 L, 12 134 
breaths/min), whereas in the subsequent animals, VLUNG was reduced to 2 liters/minute (VT 0.25, 135 
8 breaths /min) as V-A ECMO was started and kept constant thereafter. In all animals 5 cmH2O 136 
PEEP and volume control mode was used (Servo-i, Maquet, Solna, Sweden). The fraction of 137 
inspired oxygen was set at 0.30. Measurements were performed in healthy animals, 30 minutes 138 
after surgery was completed. Eventually, the pigs were euthanized by injection of 40 mmol of 139 
potassium chloride and V-A ECMO stopped in deep anesthesia. Data were recorded using 140 
Labview™ (National Instruments Corp., Austin, TX,) for offline analysis with Soleasy (Alea 141 
Solutions, Zürich, Switzerland) and Matlab R2019a (MathWorks, Natick, Massachusetts, USA).  142 
Experimental protocol 143 
The experiment consisted of 3 phases with varying sweep gas/blood flow ratios (i. e. the “(V/Q-144 
ratio” of the membrane lung) in order to determine how the sweep gas/blood flow relationship at 145 
the V-A ECMO influences extracorporeal CO2 elimination (VCO2ECMO). First, we reduced QECMO 146 
and V̇ECMO in parallel (stable V/Q = 1, phase: “reduction of V&Q”, rV&QECMO). Then we lowered 147 
VECMO with a constant QECMO (V/Q towards shunt, phase: “reduction of V”, rVECMO). Finally, we 148 
tested an V-A ECMO weaning trial, where QECMO was reduced but VECMO was kept constant (V/Q 149 
towards dead space, phase: “reduction of Q”, rQECMO).  150 
QECMO and VECMO were set at 4 L/min each at baseline and afterward reduced – depending on 151 
the respective phase - to 75%, 50%, and 25% of baseline with an interval of one minute for each 152 
condition (Figure 1). The left atrial vent was clamped during these procedures and the stepwise 153 
reduction of blood flow was not supported by vasopressors or inotropes. 154 
Calculation of V̇CO2 for V-A ECMO 155 
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Expiratory concentration of CO2 at the V-A ECMO exhaust was calculated from the expiratory 156 
partial pressure of CO2 at the V-A ECMO exhaust, and used to calculate V̇CO2 (16, 23), using 157 
actual barometric pressures (on average 722mmHg). The experiments were performed at 540 158 
meters above sea level.  159 
(1) 𝑉𝐶𝑂 = FeCO ∗ 𝑉 = 𝑝𝑒𝐶𝑂 ∗ 𝑉𝑏𝑎𝑟𝑜𝑚𝑒𝑡𝑟𝑖𝑐 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 
Calculation of VCO2 for the lung 160 
Mean pulmonary expired carbon dioxide (pECO2) was calculated by averaging the end-tidal 161 
carbon dioxide (petCO2) curve over the respiratory cycle with correction for the inspiratory to 162 
expiratory (I:E) ratio: 163 
(2) 𝑝𝐸𝐶𝑂 =  𝑝𝐸𝐶𝑂 ∗ (𝐼 + 𝐸)𝐸  
This was verified by integration of the expiratory pCO2 curve, which delivers the same result.  164 
We then calculate V̇CO2LUNG:  165 (3) 𝑉𝐶𝑂 = 𝐹𝑒𝐶𝑂 ∗ 𝑉 = 𝑝𝐸𝐶𝑂 ∗  𝑉𝑏𝑎𝑟𝑜𝑚𝑒𝑡𝑟𝑖𝑐 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 
Blood flow calculations 166 
Figure 2 depicts the situation during V-A ECMO schematically. We define the following 167 
relationships, whereby Q is flow and Δv-aCO2 is the inflow-outflow difference in blood CO2 168 
content in a given segment (∆ 𝐶𝑂  is the difference between venous and aortal CO2 content, 169 ∆ 𝐶𝑂  is the difference between venous and left atrial CO2 content, ∆ 𝐶𝑂  is the 170 
difference between venous and post membrane CO2 content): 171 (4) 𝑄 = 𝑄 + 𝑄  (5) 𝑉𝐶𝑂 = 𝑉𝐶𝑂 + 𝑉𝐶𝑂  (6) 𝑉𝐶𝑂  𝑎𝑛𝑑 𝑉𝐶𝑂 = 𝑄 ∗  ∆ 𝐶𝑂 ;  𝑉𝐶𝑂 =  𝑄 ∗  ∆ 𝐶𝑂   
We then implement equation (4) and (6) into equation (5): 172 (7) 𝑄 ∗  ∆ 𝐶𝑂  =  𝑄 ∗  ∆ 𝐶𝑂 +  𝑄 ∗  ∆ 𝐶𝑂   
We now solve equation (7) for QLUNG: 173 𝑄 ∗  ∆ 𝐶𝑂  =  𝑄 ∗  ∆ 𝐶𝑂 +  𝑄 ∗  ∆ 𝐶𝑂   
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 (𝑄 + 𝑄 ) ∗  ∆ 𝐶𝑂  =  𝑄 ∗  ∆ 𝐶𝑂 +  𝑄 ∗  ∆ 𝐶𝑂  
𝑄 ∗ (∆ 𝐶𝑂 −  ∆ 𝐶𝑂 ) =  𝑄 ∗ ∆ 𝐶𝑂 −  ∆ 𝐶𝑂  
(8)  𝑄 = 𝑄 ∗ ∆ 𝐶𝑂 −  ∆ 𝐶𝑂(∆ 𝐶𝑂 −  ∆ 𝐶𝑂 )  
As we aim to calculate QLUNG with expired gas phase measurements only rather than calculating 174 
blood gas content from multiple blood gas samples, we modify equation (8) with the following 175 
assumptions. As carbon dioxide production and carbon dioxide elimination are mathematical 176 
opposites, we use the absolute value function, thus eliminating negative values. 177 (9) ∆ 𝐶𝑂  ~ |𝑉𝐶𝑂 | (10) ∆ 𝐶𝑂  ~ |𝑉𝐶𝑂 | (11) ∆ 𝐶𝑂  ~ |𝑉𝐶𝑂 |  
We now implement these equations (9-11) into equation (8).  178 
(12)  𝑄 = 𝑄 ∗ |𝑉𝐶𝑂 | −  |𝑉𝐶𝑂 ||𝑉𝐶𝑂 | −  |𝑉𝐶𝑂 |  
Equation (5) simplifies (12) to: 179 
(13) 𝑄 = 𝑄 ∗ |𝑉𝐶𝑂 ||𝑉𝐶𝑂 | 
There is a fixed relationship of QLUNG and QECMO with the respective eliminated CO2. This 180 
expresses our hypothesis that the ratio between the differences in V̇CO2ECMO and V̇CO2Lung is the 181 
same as the ratio between the differences in the respective flows (QECMO and QLUNG). In our 182 
experimental setup, we cannot expect to reach a steady state as step changes were set at 1 183 
minute. Therefore, we calculate pulmonary blood flow using the differences in V̇CO2 and QECMO 184 
during V-A ECMO weaning rather than applying it to steady state conditions. 185 
(14)∆𝑄 = ∆𝑄 ∗ ∆𝑉𝐶𝑂∆𝑉𝐶𝑂   
Normalization of uneven V/Q ratios at the V-A ECMO 186 
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During phase “rV&QECMO” with a constant V/QECMO of 1, we expect relationship (14) to work. 187 
However, ∆ V̇CO2ECMO is influenced by VECMO and QECMO. QECMO determines the amount of CO2 188 
transported towards the membrane lung, while VECMO determines the amount of CO2 eliminated 189 
over the membrane lung with a major impact on ∆ V̇CO2ECMO (10, 13, 17). ∆ V̇CO2ECMO does 190 
therefore not necessarily represent ∆QECMO, when V/QECMO differs from 1. During the phase ” 191 
rQECMO”, V̇CO2 may decouple from QECMO. Accordingly, the ratio ∆ V̇CO2ECMO/∆ V̇CO2LUNG is 192 
affected by VECMO despite unchanged blood flows.   193 
In order to correct for uneven V/Q, we normalized ∆ V̇CO2ECMO into a new variable, ∆ 194 
V̇CO2ECMONORM, only dependent on QECMO and independent of VECMO with formula (15). The 195 
correction factor f is expressed in formula (16). 196 (15) ∆𝑉𝐶𝑂 =  ∆𝑉𝐶𝑂 ∗ 𝑓 
(16) 𝑓(𝑉, 𝑄) =  𝑄 ∗ 𝑉𝑄 + 𝑐𝑉 ∗ (1 + 𝑐)  
A formal deduction of this normalization is found in the Appendix (See Appendix A, 197 
Normalization function).  198 
Statistical Analysis 199 
For statistical, mathematical and graphical analysis, we used Matlab R2019a (MathWorks, 200 
Natick, Massachusetts, USA) including an extension pack under a creative commons license for 201 
the creation of Bland-Altman plots (15). Data are presented either individually or as range. 202 
Correlation coefficients were calculated using Pearson’s square (r2). Agreement between 203 
methods (calculated and measured QLUNG) was assessed with Bland-Altman analysis. 204 
205 





At baseline VECMO and QECMO of 4 L/min, V̇CO2ECMO was between 202 and 243 ml/min, while 208 
V̇CO2LUNG was between 13 and 193 ml/min, corresponding to a measured QLUNG of 10 to 964 209 
mL/min and representing a normal V̇CO2 production for swine (6) (Step 1 for V, Q and VQ in 210 
Table 1). 211 
Measurements at the V-A ECMO 212 
Per protocol, QECMO remained unchanged from baseline during phase “rVECMO” (98 – 100 % of 213 
baseline or 3989 - 4186 l/min) and was reduced to a quarter of baseline in phase “R V/Q" (641 -214 
1178 ml/min, 16 – 29 % of baseline). In phase “rQECMO”, QECMO was reduced to approximately a 215 
quarter in all animals except animal 3  due to hemodynamic instability (25.4 – 49.5% of baseline 216 
or 1048 -1994 ml/min)  (Table 1). 217 
The normalization function was calculated by fitting our data points into formula (16) and 218 
retrieving the constant c = 1.157 (r2 = 0.995, p < 0.001). V̇CO2ECMONORM correlated highly with 219 
QECMO and the normalization improves correlation significantly (Figure 3A and B). In phase 220 
“rVECMO”, reducing VECMO without any change in QECMO, V̇CO2ECMONORM was 194 – 249 ml/min or 221 
93.3 – 100.1 % of baseline. Without normalization, V̇CO2ECMO decoupled from QECMO with a 222 
decrease from 205 – 246 ml/min to 73 – 96 ml/min in this phase (Table 1, Figure 4B). V̇CO2ECMO 223 
values for phase: “rV&QECMO" dropped to roughly a quarter from baseline (64 - 74 ml/min, 25 – 224 
33% of baseline) in parallel with reduced QECMO. During phase: “rQECMO", V̇CO2ECMONORM was 84 225 
– 156 ml/min or 38 – 58 % of baseline. 226 
Measurements at the lung  227 
During unchanged QECMO (phase “rVECMO”) QLung remained close to baseline (2 - 980 ml/min) and 228 
did not change much within one animal and V̇CO2 stayed constant, accordingly. 229 
During reduction of QECMO in phase “rV&QECMO” and phase “rQECMO”, QLUNG increased from its low 230 
baseline values to 928 - 1550 ml/min, and 328 - 1914 ml/min, respectively (Table 1).  V̇CO2LUNG 231 
followed the changes in QLUNG to 74 – 232 ml/min (rise of 28 – 57 ml/min from baseline, with 232 
stepwise increases in every animal) for “rV&QECMO” and 39 – 233 ml/min for “rQECMO” (rise of 18 233 
– 45 ml/min from baseline), and remained steady at full QECMO (phase “rVECMO”, 21 – 188 ml/min, 234 
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change of 7 – 8 ml/min from baseline) (Table 2). QLUNG and V̇CO2LUNG showed a high correlation 235 
(Figure 4). 236 
Calculation of QLUNG 237 
The calculation of pulmonary blood flow from absolute V̇CO2 values is imprecise and leads to a 238 
consistent overestimation (Table 1). This overestimation increases with increasing V/Q ratio at 239 
the lung, which is shown in animal 1, where we had increased ventilation compared to the other 240 
animals. In phase “rVECMO”, we observe no change in measured QLUNG as well as calculated 241 
changes in QLUNG , When differences between the short stepwise flow reductions are considered 242 
(Table 2), correlations are reestablished (Figure 5B) and the respective Bland Altman Plot 243 
(Figure 5A) shows a small bias with acceptable limits of agreement. True blood flow changes are 244 
underestimated since bias is positive. Bias stays constant over the measured range (R2 = -0.16, 245 
p = 0.5). When the phase “rVECMO” is excluded due to no expected change in blood flow, out of 246 
23 blood flow change calculations, an opposite direction of the flow change is calculated in four 247 
instances. In all of these instances, the value of the change is below the least significant change, 248 
which is 113 ml/min. When the entire reduction steps are summarized (Table 2 and Figure 5C), 249 
the relationship becomes overt.  250 




We show in a preliminary analysis that measurements of V̇CO2 at both lung and V-A ECMO are 252 
possible with simple side-stream technology. Our model for the estimation of changes in QLUNG 253 
predicts the directional change of pulmonary blood flow, i. e. cardiac output with acceptable 254 
accuracy in this small sample size (3). The measurements needed for our calculations (QECMO, 255 
VECMO, VLUNG, peCO2ECMO, etCO2LUNG) are easily performed with use of standard side-stream 256 
capnographs, all of which are readily available in an ICU setting or an operating theater and 257 
require no specific training.  258 
As expected from the ventilation-perfusion concept and the gas content equations in figure 2 259 
(14), we found that a decrease in QECMO and the consecutive increase in QLUNG leads to a 260 
respective change in V̇CO2LUNG and V̇CO2ECMONORM. A closer look at formula (8) as the 261 
background of our hypothesis shows an adaptation of the classic Berggren-shunt equation (11). 262 
This seems intuitive, as the V-A ECMO is in concept an anatomical right-to-left shunt, where the 263 
ability to ventilate and oxygenate the shunted blood will clearly affect its functional influence 264 
(Figure 2). Changing the sweep gas/blood flow ratio on the ECMO will vary the function of this 265 
anatomical shunt from true shunt (VECMO = 0 at any QECMO) to dead space (QECMO = 0 at any 266 
V̇ECMO). V̇CO2ECMO only represents the shunt correctly, as long as sweep gas/blood flow on the V-267 
A ECMO are kept at a ratio of 1 (in phase “rV&QECMO”). For sweep gas/blood flow ratios differing 268 
from one, sweep gas flow (VECMO) will drastically change the amount of the eliminated CO2 (10, 269 
17) independently of blood flow - a known phenomenon in states of shock or multiorgan failure 270 
(13). We could simulate this in the derivation of our normalization procedure (See Appendix A, 271 
Appendix figures 2 and 3) and reproduce it in the experiment during the steps “rVECMO” (Table 1). 272 
The normalization of V̇CO2ECMO reestablishes a sweep gas/blood flow ratio of 1, and therefore 273 
restores the correlation between V̇CO2ECMONORM and QECMO. This newly calculated V̇CO2ECMONORM 274 
now is only dependent on blood flow and independent from ventilation and thus eliminates the 275 
influence of V/QECMO mismatch on blood flow calculations. We used our data to calculate the 276 
constant c with a curve fitting function, in order to stay independent from blood gas 277 
measurements, although individual calculations would be possible to  from pre-membrane pH. 278 
We see the high goodness of fit of this normalization procedure as an indirect proof of the 279 
normalization function (See Appendix A, Appendix figure 6). During V-A ECMO weaning with a 280 
sweep gas/blood flow ratio of 1, it seems of little practical importance. Normalization might be 281 
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particularly helpful to wean a low blood flow system with the primary intention to eliminate CO2, 282 
where the effect of increased ventilation is most relevant (5). (See Appendix A, Appendix figure 283 
3). Whether this might be applicable to a veno-venous configuration would need to be 284 
investigated. In a veno-arterial configuration, normalization might allow accurate estimations of 285 
post-membrane CO2 pressures in blood, enabling a continuous gaseous oxygenator 286 
measurement to derive blood gas tensions (See Appendix A, figure 2).  287 
A high V/QLung ratio will significantly increase the overall amount of CO2 eliminated and thus lead 288 
to an overestimation of pulmonary blood flow, while a reduction in VECMO will lead to a decrease 289 
in eliminated CO2 and thus to a rise in venous CO2 content. This in turn increases V̇CO2LUNG, to 290 
achieve a new steady state. However, as the V-A ECMO and the lung both drain venous blood 291 
from the right atrium, V̇CO2ECMO should increase simultaneously with the new steady state in 292 
order to fulfill formula (5). Our short measurement periods did preclude a steady state for CO2 293 
elimination. Calculations of total blood flow for any given moment may therefore be impossible, 294 
because the lack of a steady state does not allow for sufficient accuracy. As we calculated QLUNG 295 
through a deliberate step change in V̇CO2, a steady state is not necessary, as there is no need 296 
for an absolute reference point. This also allows the calculations for different settings of VLUNG 297 
(as shown with animal 1), as long as VLUNG remains constant. 298 
The ratio of ventilation to perfusion in the lung will vary with hypoxic vasoconstriction, shunt, 299 
alveolar collapse and dead space. Our V̇CO2LUNG – estimated from end-tidal pCO2 in healthy 300 
lungs - showed an acceptable relationship with QLUNG, but stable minute ventilation on the lung 301 
was mandatory. As QLUNG is the quantity to be calculated, a normalization procedure is not 302 
possible. As V̇CO2LUNG can only represent blood flow that participates in gas exchange, shunt 303 
due to supine positioning of the animals could explain the bias of underestimation of changes in 304 
pulmonary blood flow with our method.  305 
There are several possible limitations to our method: Firstly, a V/QLUNG mismatch (e.g. high shunt 306 
and/or high dead space) might result in a decrease of QLung – V̇CO2Lung correlation and might thus 307 
increase the bias significantly. Secondly, we did not document every V-A ECMO flow change 308 
with blood gas samples, because our aim was to calculate QLUNG using gaseous measurements. 309 
Nevertheless, a meticulous documentation of blood gas status would strengthen our hypothesis 310 
and allow for alternative calculations of gas content and direct calculations of the normalization 311 
function. Thirdly, V̇CO2 was calculated using side-stream capnography, which are of limited 312 
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accuracy. Signal shifts in the pCO2-time tracing may introduce an error here. We did not rely on 313 
a breath-by-breath measurement, but averaged values over one minute may help to minimize 314 
this possible influence. Mainstream calorimetric modules are available and used in assessing 315 
cardiac output, alveolar and dead space ventilation (7, 18-20). Mainstream capnography at the 316 
V-A ECMO gas outlet is feasible and may deliver accurate results for V̇O2 and V̇CO2 (4, 22). 317 
This might improve our results and overall accuracy compared to our calculations from side-318 
stream end-tidal carbon dioxide.  Fourthly, this study was conducted in a small, clearly 319 
preliminary set of healthy animals and without any cardiovascular support. 320 
The large scatter in pulmonary flow reflects the individual variability of native cardiac output 321 
during V-A ECMO treatment. In conclusion, we show that measurement of V̇CO2 at the V-A 322 
ECMO are easily performed. A normalization procedure allows estimation of V̇CO2 only 323 
dependent on blood flow without the influence of a V/Q mismatch. This in turn lays the basis of 324 
blood flow calculations using V̇CO2 values. Calculations of pulmonary blood flow using absolute 325 
values of carbon dioxide elimination are not possible in a non-steady state with our method. The 326 
concept can be derived from basic physiological equations. Whether our method may result in a 327 
clinically useful approach and support V-A ECMO weaning, where assessment of cardiac output 328 
may help to evaluate weanability, has to be further evaluated. These preliminary findings need 329 
further confirmation in a larger study, also investigating low and high V/Q states at the lung 330 
before exploring clinical applications.  331 
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Figure legends 407 
Figure 1. Experimental protocol with stepwise reduction of V̇ECMO and/or QECMO. 408 
Figure 2. Schematics for V-A ECMO. ∆ 𝐶𝑂  is the difference between venous and aortal CO2 409 
content, ∆ 𝐶𝑂  is the difference between venous and left atrial CO2 content, ∆ 𝐶𝑂  is the 410 
difference between venous and post membrane CO2 content. 411 
Figure 3: Effect of the normalization of the Sweep Gas Flow to Blood Flow Ratio on the V-A 412 
ECMO A: Scatter plot for QECMO vs. V̇CO2ECMO. Smallest points represent phase: “rVECMO", 413 
middle sized points represent phase “rQECMO”, large points represent phase: “rV&QECMO”. No 414 
correlations reached significant levels (p < 0.05). B: Scatter plot for QECMO vs. V̇CO2ECMONORM, all 415 
data points considered. Smallest points represent phase: “rVECMO”, middle sized points represent 416 
phase: “rQECMO” large points represent phase: “rV&QECMO”. In the phase “rQECMO”, animal 3 did 417 
not tolerate the last reduction in V-A ECMO flow. 418 
Figure 4: Correlation between Lung Blood Flow and Carbon Dioxide Elimination at the Lung, 419 
absolute values. Scatter plot for QLUNG vs. V̇CO2LUNG, all data points considered. Smallest points 420 
represent phase “rVECMO”, middle sized points represent phase: “rQECMO ", large points represent 421 
phase: “rV&QECMO”. Note that in animal 1 ventilation and thus V̇CO2Lung is high, because baseline 422 
settings at respirator were 5.6l/min (TV 465ml, 12 times / minute). This was the first animal and 423 
the ventilator settings were not adjusted from previous settings. In the phase “rQECMO”, animal 3 424 
did not tolerate the last reduction in V-A ECMO flow. 425 
Figure 5 A: Bland Altman plot for all data points during V-A ECMO Weaning. Bias is positive but 426 
close to zero with wide limits of agreement. Bias stayed constant over increasing changes in 427 
QLung (R2 = 0.014). B: Scatter plot for the real change in QLung vs. the calculated change in QLung 428 
during V-A ECMO weaning. Smallest points represent phase: “rVECMO”, middle sized points 429 
represent phase “rQECMO”, large points represent phase “rV&QECMO”. Linear regressions yield : 430 
Animal 1: y = 0.75 * x + 73.34, Animal 2: y = 0.44 * x – 47.85, Animal 3: y = 0.73 * x + 7.17, 431 
Animal 4: y = 0.8 * x – 30.17. C: Scatter plot for subsumed weaning steps for each animals. 432 
Linear regressions yield: Animal 1: y = 0.91 * x + 125.05, Animal 2: y = 0.47 * x – 166.98, Animal 433 
3: y = 0.70 * x + 34.8, Animal 4: y = 0.79 * x – 84.95. 434 
  435 
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Appendix A 436 
Normalization function 437 
1 Formal derivation of a normalized VCO2 for a 438 
ventilation/perfusion ratio of one 439 
As V̇CO2ECMO is dependent on the sweep gas flow (17), normalization of the V̇CO2 at any given 440 
V̇/Q ratio to a ventilation/perfusion (V/Q) ratio of 1 (V̇CO2ECMONORM) will render a variable only 441 
dependent on blood flow (QECMO) and independent from ventilation (VECMO). This may facilitate 442 
the blood flow prediction in the lung.  443 
The theoretical deduction of this normalization is based on the description of the V/Q ratio as (8): 444 
(1) =  𝜎 ∗ 𝑅 ∗ 𝑇 ∗ (1 + 𝐾 ) ∗    445 
σCO2 is the solubility of CO2 in blood, R is the gas constant, T is temperature. PvCO2 is venous 446 
partial pressure and PPMCO2 is the post membrane CO2 partial pressure. We assume that 447 
PPMCO2 is equal to PeCO2ECMO, which is measured at the V-A ECMO gas outlet. Kc indicates the 448 
equilibration constant of the CO2 + H2O ↔ HCO3- + H+ reaction at a given pH. It describes the 449 
additional liberation of gaseous carbon dioxide from bicarbonate during the passage through the 450 
membrane lung. pK is the acid dissociation constant.  451 
𝐾 = 𝑘𝑘 ∗ 𝐻 ; 𝑤ℎ𝑒𝑟𝑒 log10 𝑘𝑘  = −6.1 = 𝑝𝐾 
We assume the following values for BTPS conditions: 452 
𝑅 = 62.363 (𝐿 ∗  𝑚𝑚𝐻𝑔)(𝐾 ∗  𝑚𝑜𝑙)  𝑇 = 310.5 𝐾𝑒𝑙𝑣𝑖𝑛 (𝐾) 𝐾 = 12   𝑝𝐻 = 7.35 𝜎 = 3.3 ∗ 10 𝑀𝑜𝑙𝑎𝑟𝑚𝑚𝐻𝑔 
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Under the assumption of a constant pH, we can combine these individual constants into one 453 
overall constant c. 454  𝑐 = 𝜎 ∗ 𝑅 ∗ 𝑇 ∗ (1 + 𝐾 ) 
For the derivation, we assume a constant venous carbon dioxide partial pressure and calculate 455 
gas fraction of expired CO2 (FeCO2). 456 𝑃 = 45 𝑚𝑚𝐻𝑔 
𝐹𝑒𝐶𝑂 = 𝑝𝑒𝐶𝑂𝑏𝑝 ;  𝑏𝑝 = 𝑏𝑎𝑟𝑜𝑚𝑒𝑡𝑟𝑖𝑐 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 =  760 𝑚𝑚𝐻𝑔 
 457 
We solve eq. 1 for PPMCO2.  458 
(2)𝑃 = 𝑝𝑒𝐶𝑂 = 𝑐 ∗  𝑃(𝑉𝑄 + 𝑐) 
A plot of this function shows the known hyperbolic dependency of alveolar, i. e postmembrane 459 
pCO2 from ventilation (V and Q values are assumed from 0 to 4 with an interval of 0.25 l/min). 460 




Appendix Figure 1. Colors refer to different V/Q data points resulting from the chosen interval of 0.25. 462 
 463 
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Appendix Figure 2 464 
The next step is to calculate V̇CO2ECMO and plot the function (Appendix figure 3). Note, that the 465 
factor 1000 is needed to convert the results in ml/min.  466 
(3) 𝑉𝐶𝑂 = 𝐹𝑒𝐶𝑂 ∗ 𝑉 = 𝑉 ∗ 𝑐 ∗ 𝑃𝑉𝑄 + 𝑐 ∗ 1000760  
 467 
Appendix Figure 3 468 
The diverging effects of the ventilation on the ECMO on PCO2 and VCO2 become apparent. In 469 
order the represent blood flow, we now normalize the given V̇CO2 to a V̇/Q ratio of 1. 470 
We define the correction factor f as the ratio of V̇CO2 at V/Q = 1 to the V̇CO2 at any V/Q. We plot 471 
this correction factor f against V/Q. 472 
(4) 𝑓(𝑉, 𝑄) = 𝑉𝐶𝑂 𝑉𝑄 = 1𝑉𝐶𝑂  
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𝑓 = 𝑉 ∗ 𝑐 ∗ 𝑃(1 + 𝑐) ∗ 1000760𝑉 ∗ 𝑐 ∗ 𝑃𝑉𝑄 + 𝑐 ∗ 1000760 =
𝑉 ∗ 𝑉𝑄 + 𝑐𝑉 ∗ (1 + 𝑐)  
As VV/Q=1 is equal to Q, we can write: 473 
(5) 𝑓(𝑉, 𝑄) =  𝑄 ∗ 𝑉𝑄 + 𝑐𝑉 ∗ (1 + 𝑐) = 𝑉𝑄 + 𝑐(1 + 𝑐) ∗ 1𝑉/𝑄 
 474 
This describes a hyperbolic dependency of f from V/Q scaled with V/Q and c (Appendix figure 4). 475 
Note that for a V/Q of 1, the scaling and correction factor is 1. 476 
 477 
Appendix Figure 4: Colors refer to different V/Q data points resulting from the chosen interval of 0.25. 478 
Now, VCO2NORM can be calculated using eq. (3, 5). We plot this new function VCO2NORM, which is 479 
independent of V or V/Q (Appendix figure 5). 480 
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 (6) 𝑉𝐶𝑂 = 𝑉𝐶𝑂 ∗ 𝑓(𝑉, 𝑄) 
= 𝑉 ∗ 𝑐 ∗ 𝑃𝑉𝑄 + 𝑐 ∗ 1000760 ∗ 𝑄 ∗
𝑉𝑄 + 𝑐𝑉 ∗ (1 + 𝑐)  
= 𝑄 ∗ 𝑐 ∗ 𝑃(1 + 𝑐) ∗ 1000760  
It is clear from this resolved eq. (6), that V̇CO2NORM is dependent on Q and PvCO2, as well as the 481 
constant c which itself is dependent on temperature and pH.  482 
It seems intuitive, that this equation (6) can simply be achieved by implementing V/Q = 1 and 483 
substituting Q for V in eq. (3). This calculation eliminates the dependency of ventilation and 484 
VCO2NORM will represent blood flow at any V/Q (see Appendix figure 5). 485 
 486 
 487 
Appendix Figure 5 488 
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This derivation assumes perfect conditions and depends on venous pvCO2 and pH, which are as 489 
a limitation of our study unknown. Therefore, the function has to be approximated from 490 
measured data, as described in the following section. 491 
  492 
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2 Retrieving the normalization function from measured Data 493 
We calculated the necessary correction factors using the measured data and eq. 4.  494 
Then, the correction factors were plotted against V̇/Q and the coefficient c was received 495 
(Appendix figure 6).  496 
(7) 𝑓(𝑉 , 𝑄 ) =  𝑄 ∗ 𝑉𝑄 + 𝑐𝑉 ∗ (1 + 𝑐) ; 𝑐 = 1.157;  95%  𝐶𝐼 𝐼𝑛𝑡𝑒𝑟𝑣𝑎𝑙: 1.097,1.216 ; 𝑟 = 0.9954  
 497 
Appendix Figure 6 498 
It is a limitation of our study that our measurements of sweep gas flow (set and read by hand) 499 
are much more inaccurate than the blood flow readings. Additionally, instantaneous PvCO2 and 500 
pH measurements to calculate c are not available. Inexact ventilation measurements will 501 
introduce an error in the position of the normalization curve, where a small shift around a V̇/Q of 502 
1 will have a large impact on the slope of the function. Small errors in measurement of V̇CO2, V̇ 503 
or Q will therefore largely influence c (Appendix figure 4). However, the calculated function with 504 
empirically derived c shows almost perfect goodness of fit and the normalization of V̇CO2ECMO 505 
with this correction function shows very strong correlations between V̇CO2ECMONORM and QECMO 506 
within the range of our measurements (Figure 3, manuscript).   507 
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Table 1: Individual data sets 
  
Animal 1  Animal 2  
ECMO Lung ECMO Lung 
V Q VCO2 VCO2 norm V Q VCO2 Qcalc V Q VCO2 VCO2 norm V Q VCO2 Qcalc 
Step [ml/min] [ml/min] [ml/min]   
V 
1 4000 4105 214 217 5600 964 189 3572 4000 4013 222 223 1800 389 52 935 
2 3000 4092 177 212 5600 917 189 3647 3000 4010 194 229 1800 387 61 1077 
3 2000 4049 135 209 5600 1125 195 3778 2000 3982 150 229 1800 370 66 1141 
4 1000 4071 77 203 5600 980 196 3934 1000 3994 86 223 1800 358 60 1065 
Q 
1 4000 4113 226 229 5600 920 197 3529 4000 4079 259 261 1800 105 64 1006 
2 4000 3147 202 179 5600 1035 200 3520 4000 3016 236 205 1800 503 73 1073 
3 4000 2058 173 128 5600 1458 215 3463 4000 1995 205 150 1800 968 72 966 
4 4000 1207 140 88 5600 1915 244 3348 4000 1048 160 97 1800 1349 87 944 
VQ 
1 4000 4068 211 213 5600 843 202 3859 4000 4016 245 245 1800 126 75 1236 
2 3000 3231 168 174 5600 1157 199 3686 3000 3008 195 195 1800 560 76 1170 
3 2000 2191 120 126 5600 1376 227 3945 2000 2019 142 143 1800 991 88 1245 
4 1000 1178 66 73 5600 1550 242 3932 1000 1094 67 71 1800 1472 105 1626 
Animal 3  Animal 4  
ECMO Lung ECMO Lung 
V Q VCO2 VCO2 norm V Q VCO2 Qcalc V Q VCO2 VCO2 norm V Q VCO2 Qcalc 
Step [ml/min] [ml/min] [ml/min] [ml/min] 
V 
1 4000 4062 263 266 1800 10 14 217 4000 4170 239 244 2000 59 22 378 
2 3000 4043 228 270 1800 10 18 264 3000 4216 197 240 2000 72 30 528 
3 2000 4025 177 274 1800 5 19 283 2000 4188 154 244 2000 39 34 592 
4 1000 3989 102 266 1800 2 22 333 1000 4186 89 241 2000 21 32 561 
Q 
1 4000 4031 287 288 1800 4 23 324 4000 4177 248 254 2000 9 31 515 
2 4000 2966 261 225 1800 8 22 296 4000 3031 225 195 2000 294 36 556 
3 4000 1994 228 167 1800 328 42 502 4000 2064 192 142 2000 616 58 845 
4 N/A N/A N/A N/A N/A N/A N/A N/A 4000 1060 149 91 2000 909 68 801 
VQ 
1 4000 4074 260 262 1800 9 42 651 4000 4031 231 232 2000 14 49 848 
2 3000 3008 211 211 1800 36 37 529 3000 3098 188 191 2000 259 55 899 
3 2000 1973 168 167 1800 399 57 677 2000 2108 138 142 2000 602 65 964 
4 1000 641 79 64 1800 1327 103 1035 1000 1051 75 78 2000 928 78 1060 
 
Downloaded from journals.physiology.org/journal/ajplung at Univ Bern Hosp (161.062.252.040) on April 17, 2020.
Table 1. Individual data for all animals at baseline (step 1 at V, Q, and VQ) and every step of blood flow reduction. ECMO Q and Lung Q 
denote readings from the respective flow probes, VCO2 values were calculated according to formulas 1 to 3 in the method section using 
reported barometric pressure for each day (728, 726, 711 and 721 mmHg). Note that 1) in animal 1 ventilation is high because baseline 
settings at respirator were 5.6l/min (TV 465ml, 12 Freq) and that 2) during phase: “reduction of Q” the cardiovascular system of animal 3 
did not support the ECMO Reduction to 25 % of baseline, therefore no measurement is available. VCO2norm refers to a calculated 
VCO2 for a sweep gas/blood flow ratio normalized towards one (details see Appendix). 
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Table 2: stepwise reductions 
  
Animal 1  Animal 2    
ECMO Lung ECMO Lung 
ΔV ΔQ ΔVCO2 ΔVCO2 norm ΔV ΔQ ΔVCO2 ΔQ Calculated ΔV ΔQ ΔVCO2 ΔVCO2 norm ΔV ΔQ ΔVCO2 ΔQ Calculated
Step [ml/min] [ml/min] [ml/min] [ml/min]   
V 
1 -> 2 -1000 -13 -37 -6 0 -47 0 -1 -1000 -3 -27 6 0 -2 9 -5 
2 -> 3 -1000 -43 -42 -2 0 208 7 122 -1000 -28 -42 1 0 -17 4 -189 
3 -> 4 -1000 22 -59 -7 0 -145 1 -2 -1000 12 -61 -6 0 -13 -6 12 
summed up -3000 -34 -138 -15 0 16 7 119 -3000 -19 -130 1 0 -32 7 -181 
                                    
Q 
1 -> 2 0 -966 -24 -50 0 115 3 66 0 -1063 -22 -56 0 398 9 160 
2 -> 3 0 -1089 -29 -51 0 423 15 313 0 -1021 -31 -55 0 465 0 -9 
3 -> 4 0 -851 -32 -40 0 457 28 605 0 -947 -44 -53 0 381 15 268 
summed up 0 -2906 -86 -142 0 995 47 984 0 -3031 -98 -164 0 1244 23 419 
                                    
VQ 
1 -> 2 -1000 -837 -43 -38 0 314 -3 -59 -1000 -1008 -50 -50 0 434 0 7 
2 -> 3 -1000 -1040 -47 -48 0 219 28 612 -1000 -989 -52 -52 0 431 12 236 
3 -> 4 -1000 -1013 -54 -54 0 174 15 286 -1000 -925 -75 -72 0 481 17 217 
summed up -3000 -2890 -144 -140 0 707 41 838 -3000 -2922 -177 -174 0 1346 30 460 
Animal 3  Animal 4  
ECMO Lung ECMO Lung 
ΔV ΔQ ΔVCO2 ΔVCO2 norm ΔV ΔQ ΔVCO2 ΔQ Calculated ΔV ΔQ ΔVCO2 ΔVCO2 norm ΔV ΔQ ΔVCO2 ΔQ Calculated
Step [ml/min] [ml/min] [ml/min] [ml/min] 
V 
1 -> 2 -1000 -19 -36 4 0 0 3 -15 -1000 46 -42 -4 0 13 8 -84 
2 -> 3 -1000 -18 -50 4 0 -5 2 -8 -1000 -28 -43 4 0 -33 4 -31 
3 -> 4 -1000 -36 -75 -8 0 -3 3 13 -1000 -2 -65 -2 0 -18 -2 -2 
summed up -3000 -73 -161 0 0 -8 8 -9 -3000 16 -150 -3 0 -38 10 -117 
                                    
Q 
1 -> 2 0 -1065 -25 -63 0 4 -1 -11 0 -1146 -24 -59 0 285 4 88 
2 -> 3 0 -972 -33 -58 0 320 20 326 0 -967 -32 -53 0 322 22 410 
3 -> 4 N/A N/A N/A N/A N/A N/A N/A N/A 0 -1004 -43 -52 0 293 10 196 
summed up 0 -2037 -59 -121 0 324 19 315 0 -3117 -99 -164 0 900 37 693 
                                    
VQ 
1 -> 2 -1000 -1066 -49 -51 0 27 -5 -99 -1000 -933 -43 -40 0 245 7 158 
2 -> 3 -1000 -1035 -43 -45 0 363 20 459 -1000 -990 -50 -49 0 343 10 195 
3 -> 4 -1000 -1332 -89 -103 0 928 45 588 -1000 -1057 -63 -65 0 326 13 213 
summed up -3000 -3433 -181 -199 0 1318 61 948 -3000 -2980 -155 -154 0 914 29 565 
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Table 2. Individual data for all animals for measurements performed at the lung. Note, that during phase: “reduction of Q” the 
cardiovascular system of animal 3 did not support the ECMO Reduction to 25 % of baseline, therefore no measurement is available. 
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